SCHEMBL11864242

SCHEMBL11864242

COC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)CN

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 2/20 0.68
▸ XDH P47989 2/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ LNPEP Q9UIQ6 1/20 0.48
▸ MDM4 O15151 1/20 0.48
▸ MDM2 Q00987 1/20 0.48
▸ MMP1 P03956 1/20 0.47
▸ MMP2 P08253 1/20 0.47
▸ MMP3 P08254 1/20 0.47
▸ MMP9 P14780 1/20 0.47
▸ MMP12 P39900 1/20 0.47
▸ MMP13 P45452 1/20 0.47
▸ HDAC1 Q13547 5/20 0.47
▸ HDAC6 Q9UBN7 5/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ USP2 O75604 1/20 0.47
▸ EGFR P00533 1/20 0.47
▸ FYN P06241 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11854802 0.89 LCK (0.55) LCKALDH1A1MMP1MMP2MMP3
SCHEMBL6267583 0.87 LCK (0.70) LCKXDHNPSR1ALDH1A1LNPEP
SCHEMBL10099849 0.87 LCK (0.62) LCKNPSR1ALDH1A1HDAC1HDAC6
SCHEMBL10792628 0.86 LCK (0.71) LCKXDHALDH1A1LNPEPMDM4
SCHEMBL10792638 0.86 LCK (0.71) LCKXDHALDH1A1LNPEPMDM4
SCHEMBL15976477 0.86 LCK (0.71) LCKXDHNPSR1ALDH1A1LNPEP
SCHEMBL15976476 0.86 LCK (0.71) LCKXDHALDH1A1LNPEPMDM4
SCHEMBL6139811 0.85 LCK (0.67) LCKNPSR1ALDH1A1HDAC1HDAC6
Hydrochloric Acid SCHEMBL4717659 0.84 LCK (0.62) LCKXDHNPSR1ALDH1A1LNPEP
SCHEMBL11539388 0.84 LCK (0.65) LCKXDHNPSR1ALDH1A1LNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3939253-A Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease INTERX RESEARCH CORPORATION (US) 1976-02-17 — — US disclosed
Send feedback